InterAx Biotech and Vrije Universiteit Amsterdam enter a collaboration to unlock novel chemical space for chemokine therapeutics InterAx Biotech and Vrije Universiteit Amsterdam announce that they will combine complementary technologies to design bioactive molecules – so called...
Gregg Siegal new professor of Biophysical techniques for drug discovery at AIMMS The Executive Board of the VU appoints Gregg Siegal as professor of the Biophysical techniques for drug discovery chair, starting 1 April 2018.
AIMMS researchers in Dutch media Recently, AIMMS researchers Wilbert Bitter, Remco Kort and Jacob de Boer commented on various scientific topics in Dutch media.
AIMMS researchers develop nanobodies targeting a viral chemokine receptor to impair glioblastoma growth In a recent publication in Oncogene, Medicinal Chemistry researchers Raimond Heukers, Tian Shu Fan, Raymond de Wit and colleagues under supervision of...
